NCT05967156View on ClinicalTrials.gov

Empagliflozin in Heart Failure Dialysis Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

June 3, 2025

Conditions
Heart FailureHemodialysis
Interventions
DRUG

Empagliflozin10Mg Tab

10 mg daily

Trial Locations (1)

1666663421

Nooshin Dalili, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT05967156 - Empagliflozin in Heart Failure Dialysis Patients | Biotech Hunter | Biotech Hunter